Replies to post #22121 on NorthWest Biotherapeutics Inc (NWBO)

[Chiugray]

This stock is closely held, it's difficult for institutions to take a position.

That makes sense. I would venture that on the retail float side, the remaining holders are longer-term folks who won't sell due to manipulative news or PPS fluctuations.

The storm will be the next run on the news. That's the way they make their money... run it then sell at the top and short it down. Cover, rinse, repeat.

That seems to have been the history.

However I believe the "next run" cycle could last 3-12 mos with a PPS running 3X-10X. There are a number of news items that will develop, primarily Germany/UK sales and sale projections, additional countries, and interim results on L and Direct. These, if positive, will not be short term, ie not be manipulated a day later by AF. The fundamental shifts I see will result in stable institutional investors taking positions.
- PPS correction (currently extremely undervalued, go to fairly or strategically valued)
- fundamental realignment and perspective of NWBO from "speculative" to "investment"

My intuition tells me that Linda has a plan. I suspect the last 2 weeks of buying from around $4 to $5/sh today were not shorts covering, more so institutional investors. Of course my intuition has a margin of error that competes with Diamond Jim's magic eight ball.